PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-11-10

Date Title Company
10-Nov-2022 Corner Therapeutics Debuts with Data Presentation on its Dendritic Cell Hyperactivation Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting Businesswire
10-Nov-2022 Flora Growth Announces Shareholders Owning Over 73% of Shares of Franchise Global Health Support Acquisition by Flora Businesswire
10-Nov-2022 Equillium Announces Initiation of Phase 2 study of EQ101 A First-in-Class Multi-Cytokine Inhibitor of IL-2, IL-9 and IL-15 Targeting Alopecia Areata Businesswire
10-Nov-2022 Harrow Launches Atropine.com Businesswire
10-Nov-2022 Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022 Businesswire
10-Nov-2022 PharmaSGP Holding SE raises forecast for FY 2022 PharmaSGP Holding SE
10-Nov-2022 Metal Nanoparticles Global Market Report 2022: Rising Focus of Governments on Nanotechnology Research Driving Growth - ResearchAndMarkets.com Businesswire
10-Nov-2022 Stoke Therapeutics to Host Webinar and Conference Call to Present Interim Data from the Phase 1/2a Studies of STK-001 in Children and Adolescents with Dravet Syndrome Businesswire
10-Nov-2022 Last-Mile Delivery Robot Global Market Report 2022: Growth of E-Commerce and Q-Commerce Industries Drive Sector - ResearchAndMarkets.com Businesswire
10-Nov-2022 CRO Industry Leader Davide Molho Joins Summit Partners as Executive-in-Residence Businesswire
10-Nov-2022 Seagen Appoints Sandra M. Swain, M.D., to Board of Directors Businesswire
10-Nov-2022 Klick Health forma equipe e escritórios globais Businesswire
10-Nov-2022 Klick Health crea equipos y oficinas de liderazgo global Businesswire
10-Nov-2022 Silence Therapeutics Reports Third Quarter 2022 Results Businesswire
10-Nov-2022 Aldeyra Therapeutics Reports Third-Quarter 2022 Financial Results and Recent Corporate Highlights Businesswire
10-Nov-2022 Aura Biosciences Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights Businesswire
10-Nov-2022 US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations Businesswire
10-Nov-2022 Seagen Names David R. Epstein as Chief Executive Officer and Director Businesswire
10-Nov-2022 Parthenon Therapeutics and ImaginAb Announce License and Supply Agreement to Advance New Class of Anti-Cancer Therapies’ Clinical Development Program Businesswire
10-Nov-2022 BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers Businesswire